Cormorant Asset Management, LP Blueprint Medicines Corp Transaction History

Cormorant Asset Management, LP

$1.43 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $14.1 Million - $17.4 Million	-150,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $7.09 Million - $9.58 Million	-87,546 Reduced 36.85%	150,000 $15.4 Million
Q2 2021 Aug 16, 2021	SELL	$82.78 - $101.0 $799,158 - $975,054	-9,654 Reduced 3.91%	237,546 $20.9 Million
Q1 2021 May 17, 2021	BUY	$90.71 - $108.28 $2.01 Million - $2.4 Million	22,200 Added 9.87%	247,200 $24 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $4.6 Million - $6.22 Million	-50,000 Reduced 18.18%	225,000 $25.2 Million
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $4.98 Million - $6.95 Million	-75,000 Reduced 21.43%	275,000 $25.5 Million
Q2 2020 Aug 14, 2020	SELL	$57.09 - $79.27 $5.71 Million - $7.93 Million	-100,000 Reduced 22.22%	350,000 $27.3 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $5.05 Million - $8.63 Million	105,000 Added 30.43%	450,000 $26.3 Million
Q4 2019 Feb 14, 2020	SELL	$66.73 - $82.59 $9.88 Million - $12.2 Million	-148,000 Reduced 30.02%	345,000 $27.6 Million
Q3 2019 Nov 14, 2019	BUY	$72.9 - $101.41 $10.4 Million - $14.5 Million	143,000 Added 40.86%	493,000 $36.2 Million
Q2 2019 Aug 14, 2019	SELL	$73.54 - $97.8 $7.35 Million - $9.78 Million	-100,000 Reduced 22.22%	350,000 $33 Million
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $4.32 Million - $7.68 Million	88,649 Added 24.53%	450,000 $36 Million
Q4 2018 Feb 14, 2019	SELL	$45.57 - $74.26 $849,834 - $1.38 Million	-18,649 Reduced 4.91%	361,351 $19.5 Million
Q3 2018 Nov 14, 2018	SELL	$58.91 - $78.32 $10 Million - $13.3 Million	-170,000 Reduced 30.91%	380,000 $29.7 Million
Q2 2018 Aug 14, 2018	BUY	$60.96 - $101.18 $7.19 Million - $11.9 Million	117,937 Added 27.3%	550,000 $34.9 Million
Q1 2018 May 15, 2018	SELL	$73.28 - $102.95 $1.31 Million - $1.85 Million	-17,937 Reduced 3.99%	432,063 $39.6 Million
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $23.6 Million - $33.1 Million	375,000 Added 500.0%	450,000 $33.9 Million
Q3 2017 Nov 14, 2017	BUY	$42.37 - $69.67 $3.18 Million - $5.23 Million	75,000	75,000 $5.23 Million

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$593 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$590 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$478 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$352 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$245 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.3B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account